Alimera Sciences, Inc. (ALIM)
NASDAQ: ALIM · IEX Real-Time Price · USD
3.650
+0.170 (4.89%)
May 3, 2024, 4:30 PM EDT - Market closed

Alimera Sciences Revenue

In the year 2023, Alimera Sciences had annual revenue of $80.75M with 49.19% growth. Revenue in the quarter ending December 31, 2023 was $26.31M with 87.51% year-over-year growth.

Revenue (ttm)
$80.75M
Revenue Growth
+49.19%
P/S Ratio
2.37
Revenue / Employee
$524,377
Employees
154
Market Cap
191.17M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202380.75M26.63M49.19%
Dec 31, 202254.13M-4.90M-8.30%
Dec 31, 202159.03M8.21M16.15%
Dec 31, 202050.82M-3.12M-5.79%
Dec 31, 201953.94M7.34M15.76%
Dec 31, 201846.60M10.69M29.76%
Dec 31, 201735.91M1.58M4.60%
Dec 31, 201634.33M11.90M53.01%
Dec 31, 201522.44M14.02M166.39%
Dec 31, 20148.42M6.55M349.95%
Dec 31, 20131.87M--
Dec 31, 20120--
Dec 31, 20110--
Dec 31, 20100--
Dec 31, 20090--
Dec 31, 20080--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Semler Scientific 68.18M
908 Devices 50.23M
CVRx, Inc. 39.30M
MediWound 18.69M
Profound Medical 5.41M
Revenue Rankings